Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to $412500.0.

  • Biofrontera's Treasury Shares fell 833.33% to $412500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $412500.0, marking a year-over-year decrease of 833.33%. This contributed to the annual value of $450000.0 for FY2024, which is 933198.49% up from last year.
  • Latest data reveals that Biofrontera reported Treasury Shares of $412500.0 as of Q3 2025, which was down 833.33% from $450000.0 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Treasury Shares ranged from a high of $343.5 million in Q2 2022 and a low of $4771.0 during Q2 2023
  • In the last 5 years, Biofrontera's Treasury Shares had a median value of $343512.0 in 2022 and averaged $24.7 million.
  • In the last 5 years, Biofrontera's Treasury Shares tumbled by 9999.86% in 2023 and then surged by 933198.49% in 2024.
  • Quarter analysis of 5 years shows Biofrontera's Treasury Shares stood at $8504.0 in 2021, then surged by 101.98% to $17176.0 in 2022, then tumbled by 72.22% to $4771.0 in 2023, then soared by 9331.98% to $450000.0 in 2024, then dropped by 8.33% to $412500.0 in 2025.
  • Its last three reported values are $412500.0 in Q3 2025, $450000.0 for Q2 2025, and $450000.0 during Q1 2025.